Employee Stock Ownership Plans (ESOPs) — Full Lifecycle Tax Treatment from Grant to Sale

An ESOP moves through several distinct stages — grant, vesting, exercise, and eventual sale — and Pakistani tax law treats each stage differently under Section 14 of the Income Tax Ordinance, meaning an employee who only understands "I'll pay tax when I sell" is missing at least one, and often two, earlier taxable events that happen well before any actual sale takes place.

Four Distinct Stages, Four Different Tax Questions

An ESOP's lifecycle typically runs through grant (the employer gives the employee a right or option to acquire shares), vesting (the employee earns the right to actually use that option, often over a schedule), exercise (the employee actually acquires the shares, usually by paying an exercise price), and eventual sale (the employee sells the shares they now hold). Pakistani tax law under Section 14 of the Income Tax Ordinance treats these stages differently, and understanding each one separately — rather than assuming a single tax event happens only at the end — is essential to correctly planning around an ESOP.

Stage One: Grant — Not Taxable

The value of a right or option to acquire shares granted to an employee under an ESOP is explicitly not chargeable to tax at the point of grant. This means an employee receiving an ESOP grant doesn't face any immediate tax bill simply for having been granted the option — the tax law recognizes that a mere right to potentially acquire shares in the future, not yet exercised, doesn't represent income actually realized yet.

Stage Two: Exercise/Issuance — Taxed as Salary

Where an employee is actually issued shares under the ESOP — including as a result of exercising an option — the amount chargeable to tax under the "Salary" head includes the fair market value of the shares at the date of issue, reduced by any consideration the employee paid (including any amount paid for the original grant of the right or option itself). This is the first genuine taxable event in the ESOP lifecycle for most employees, and it's taxed as ordinary salary income, not as a capital gain — an important distinction, since salary income and capital gains follow different tax mechanics and rates.

Restricted Shares — Deferred Taxation

Where shares are issued to an employee subject to a restriction on transfer — a common ESOP feature, often tied to continued employment or a specific holding period — no amount is included in the employee's salary until the earlier of two events: the point the employee gains a free right to transfer the shares (the restriction lifts), or the point the employee actually disposes of the shares while still restricted. This deferral mechanism means an employee holding genuinely restricted shares doesn't face a tax bill at the point of issue itself if restrictions are still in place — the tax event is pushed forward to whichever of those two triggering events happens first.

Disposing of the Right or Option Without Exercising

Where an employee, instead of exercising a granted right or option to acquire shares, disposes of that right or option itself during the tax year — selling the option rather than using it to acquire shares — the gain derived from that disposal is included in the employee's salary. This is a distinct scenario from the standard exercise-and-hold path, but follows the same underlying principle: value genuinely realized from the ESOP arrangement, however it's realized, generally gets taxed as salary income rather than escaping taxation simply because the employee chose a different path than a straightforward exercise.

Stage Four: Selling the Shares — Capital Gains, Not Salary

Once an employee actually holds ESOP shares (having exercised, or had restrictions lift) and later sells those shares, that sale triggers separate capital gains tax treatment — following the general capital gains framework that applies to disposing of company shares, distinct from the salary-income treatment that applied at the earlier exercise/issuance stage. The employee's cost basis for this capital gains calculation is generally the fair market value already used to calculate the salary-income amount at exercise, not the (often lower) exercise price actually paid — meaning the taxable capital gain reflects only the appreciation that occurred after exercise, not the full appreciation from grant to eventual sale, since the exercise-to-issue appreciation was already captured as salary income at that earlier stage.

Why Understanding This Sequencing Matters Practically

An employee who only plans around "I'll owe tax when I eventually sell" is very likely underestimating both when tax actually becomes due and how much of the total appreciation gets taxed at which stage. The exercise/issuance stage generates a real, often substantial, salary-tax liability — potentially well before the employee has actually sold any shares to generate cash to cover that liability — which is exactly the kind of cash-flow mismatch that catches employees off guard if they haven't planned for it. Understanding that a genuine tax event occurs at exercise, not just eventual sale, is the single most important practical takeaway from this entire lifecycle.

A Note on Startup and Growth-Company ESOPs Specifically

Employees at startups and growth-stage companies — where ESOPs are especially common as a compensation tool — face a particular version of the cash-flow mismatch described above: exercising options in a private company generates a salary-tax liability based on fair market value, but the employee typically can't easily sell private company shares to generate cash for that tax bill the way an employee at a publicly listed company could. This makes the exercise-timing decision at a private, pre-liquidity company a genuinely important one to plan around carefully with a tax professional, rather than exercising options simply because a vesting schedule made them available to exercise.

The Employer's Withholding Role at Exercise

Because the exercise-stage amount is taxed as salary income, an employer generally has withholding obligations on this amount the same way they do for any other salary payment — meaning an employee exercising ESOP options at a company that handles this correctly should expect some portion of the tax liability to already be addressed through the employer's own payroll withholding process, rather than something the employee must calculate and remit entirely independently. That said, an employee should confirm directly with their employer's HR or finance team exactly how ESOP exercise withholding is being handled at their specific company, since practices can vary and an employee shouldn't simply assume this is being managed correctly without checking.

Fair Market Value at Listed vs Unlisted Companies

Determining fair market value at exercise is straightforward for a company listed on the stock exchange — the traded market price on the relevant date provides a clear, objective figure. For an unlisted, private company, fair market value requires a valuation exercise, which introduces genuine complexity and potential disagreement about the correct figure — an employee at a private company exercising ESOP options should understand how their specific company determines this valuation, since it directly drives the salary-tax amount owed, and an aggressive or overly conservative valuation approach by the company can meaningfully affect what the employee actually ends up owing at that exercise stage.

Common Mistakes

• Assuming tax only applies when the shares are eventually sold: exercise/issuance is a separate, often earlier, taxable event under the salary-income head.
• Not planning for the cash-flow mismatch at exercise, especially at a private company: a real tax liability can arise before there's any easy way to sell shares to fund it.
• Confusing the fair-market-value date: the taxable amount at exercise uses fair market value at the date of issue, not the date of the original grant.
• Not understanding that restricted shares defer, but don't eliminate, the taxable event: taxation is pushed to the earlier of the restriction lifting or disposal, not avoided entirely.
• Using the exercise price rather than fair market value at exercise as the cost basis for later capital gains calculation: this understates the correct cost basis and can lead to an inflated, incorrect capital gains figure at eventual sale.

A Worked Example

An employee is granted ESOP options at a company, facing no tax at the grant stage itself. Two years later, upon vesting, the employee exercises the options, paying the exercise price for shares now worth considerably more on the open market — this exercise triggers a salary-tax liability calculated as the fair market value at exercise minus the exercise price paid, taxed at the employee's applicable salary tax rate. Because the shares aren't subject to any further transfer restriction after exercise, this liability arises immediately rather than being deferred further. A year later, the employee sells the shares at a further-appreciated price; this sale triggers separate capital gains tax, calculated using the fair-market-value-at-exercise figure (not the original exercise price) as the cost basis — meaning only the additional appreciation since exercise, not the full gain from the original exercise price, is captured as this later capital gain.

Frequently Asked Questions